Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 13/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.36 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5382509 | 0.85 | CYP3A4 (0.42) | CYP3A4SLC22A12PRMT5WDR77 | |
| SCHEMBL5374946 | 0.85 | CYP3A4 (0.42) | ARCYP3A4PRMT5WDR77AKR1B1 | |
| SCHEMBL5366909 | 0.83 | CYP3A4 (0.46) | CYP3A4AKR1B1 | |
| SCHEMBL5373732 | 0.82 | CYP3A4 (0.45) | ARCYP3A4PRMT5WDR77 | |
| SCHEMBL5375034 | 0.82 | CYP3A4 (0.37) | ARCYP3A4SLC22A12 | |
| SCHEMBL5377568 | 0.77 | CYP3A4 (0.47) | ARCYP3A4 | |
| SCHEMBL5374482 | 0.77 | CYP3A4 (0.61) | ARCYP3A4PRMT5WDR77AKR1B1 | |
| SCHEMBL5370291 | 0.73 | CYP3A4 (0.43) | CYP3A4SLC22A12AKR1B1 | |
| SCHEMBL5365226 | 0.73 | SLC22A12 (0.40) | ARCYP3A4SLC22A12 | |
| SCHEMBL5377392 | 0.73 | CYP3A4 (0.39) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7189718-B2 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC (US) | 2007-03-13 | — | — | US | disclosed |
| US-7189718-B2 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC (US) | 2007-03-13 | — | — | US | disclosed |
| US-7189718-B2 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC (US) | 2007-03-13 | — | — | US | disclosed |